Metrics
44 Record Views
- Title
- Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor
- Creators
- F Janku - The University of Texas MD Anderson Cancer Center, Department of Investigational Cancer Therapeutics, Huston, USAE.J Sherman - MSKCC, Department of Medical Oncology, New York, USAA.R Parikh - Massachusetts General Hospital, Department of Medicine, Boston, USAL.G Feun - Sylvester Comprehensive Cancer Center- University of Miami, Department of Medicine, Miami, USAF Tsai - Honor Health, Department of Medicine, Scottsdale, USAE Allen - Texas Children’s Cancer Center- Baylor College of Medicine, Department of Pediatrics, Huston, USAC Zhang - Plexxikon, Plexxikon, Berkeley, USAP Severson - Plexxikon, Plexxikon, Berkeley, USAK Inokuchi - Plexxikon, Plexxikon, Berkeley, USAJ Walling - Plexxikon, Plexxikon, Berkeley, USAS Averbuch - Novellus Bio, Novellus, Jerusalem, IsraelG Tarcic - Novellus Bio, Novellus, Jerusalem, IsraelG Bollag - Plexxikon, Plexxikon, Berkeley, USA
- Publication Details
- European journal of cancer (1990), Vol.138, pp.S2-S3
- Publisher
- Elsevier Ltd
- Academic Unit
- UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031576903402976